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Overlapping Probabilities of Top Ranking Gene Lists, Hypergeometric
Distribution, and Stringency of Gene Selection Criterion
Wen Fury, Franak Batliwalla, Peter K. Gregersen, and Wentian Li
Abstract— When the same set of genes appear in two top
ranking gene lists in two different studies, it is often of
interest to estimate the probability for this being a chance
event. This overlapping probability is well known to follow the
hypergeometric distribution. Usually, the lengths of top-ranking
gene lists are assumed to be fixed, by using a pre-set criterion
on, e.g., p-value for the t-test. We investigate how overlapping
probability changes with the gene selection criterion, or simply,
with the length of the top-ranking gene lists. It is concluded
that overlapping probability is indeed a function of the gene
list length, and its statistical significance should be quoted in
the context of gene selection criterion.
I. INTRODUCTION
One of the most common tasks in microarray analysis is
to identify a list of genes that are differentially expressed
under two conditions, such as being affected by a disease
vs. normal, before vs. after a medical treatment, and one vs.
another disease subtype. The number of genes on the top-
ranking list is usually much smaller than the total number of
genes on the chip, n. If the same type of microarray chip is
used for two different studies (e.g. disease-A vs. control, and
disease-B vs. control), two differentially expressed gene lists
can be obtained, with n1 and n2 genes. Researchers often
find the same genes appear in both lists and hypothesize
that these common genes are involved the etiology of both
diseases.
However, for such a hypothesis to be convincing, one
has to first estimate the probability for overlapping genes
by chance alone. In other words, if two lists of genes are
selected out of n genes randomly, we would like to calculate
the probability for m genes in common in the two lists, with
the lengths of the two lists being n1 and n2. This overlapping
probability is known to follow the hypergeometric distribu-
tion 1. The name hypergeometric distribution was first used
in [1], and was popularized by its role in Fisher’s exact test
[2].
In microarray analysis, overlapping probability and hyper-
geometric distribution mainly appear in testing the enrich-
ment of genes in certain functional category [3], [4], [5],
[6], [7], [8], [9], [10]. In this application, the first list is
the top-ranking differentially expressed genes, and a gene
W. Fury is a Senior Bioinformatics Scientist at Regeneron Pharmaceuti-
cal, Inc. Tarrytown, NY 10591, USA. wen.fury@regeneron.com
F. Batliwalla, P.K. Gregersen, and W. Li are Research Scientists with
the Robert S Boas Center for Genomics and Human Genetics, Fein-
stein Institute for Medical Research, North Shore LIJ Health System,
Manhasset, NY 11030, USA fb@nshs.edu, peterg@nshs.edu,
wli@nslij-genetics.org
1Despite certain similarity, this problem is not the birthday problem – the
probability for two people in a room to have the same birthday.
selection process is involved. The second list is nevertheless
given: n2 genes are known to be in a pathway, a member
of a protein family, described by a gene ontology term, etc.
One asks the question on chance probability for m out of
n1 selected genes to be in a given pathway, a protein family,
and describable by a gene ontology term. Fixing n2 or not
is the main difference between their application and ours.
When a different gene selection criterion is used, the
number of genes in the two top-ranking lists of two studies
(n1 and n2) will also change. Because the stringency of a
gene selection criterion is always adjustable and to some
extent arbitrary, we would like to examine whether these
changes will affect the overlapping probability. At two ex-
treme situations, very small n1 = n2 ≈ 1 and very large
n1 = n2 = n, it is clear that the number of overlapping
genes is m = 0 and m = n. These m values appear 100%
of the times, so the corresponding p-value is equal to 1, i.e.,
not significant. For intermediate n1 ≈ n2 values, it is not
clear what the overlapping probability and significance will
be, and it is the topic of this abstract.
II. HYPERGEOMETRIC DISTRIBUTION AND
OVERLAPPING P-VALUES
Given integers n, n1, n2, m (max(n1, n2) ≤ n and m ≤
min(n1, n2) ), the hypergeometric distribution is defined as
P (m) =
C(n1,m)C(n− n1, n2 −m)
C(n, n2)
=
(
n1
m
)(
n− n1
n2 −m
)
(
n
n2
)
where C(n,m) is the number of possibilities of choosing m
objects out of n objects: C(n,m) = n!/[m!(n−m)!].
When n1 genes are randomly chosen from the total of n
genes, and another random sampling leads to n2 genes, the
probability that the two lists of genes have m in common
is exactly the hypergeometric probability P (m). This can be
proven by the following steps: 1) The total number of possi-
ble choices for the two lists of genes is C(n, n1) ·C(n, n2).
2) There are C(n, n1) possibilities for choosing the first list.
3) Among the n1 genes in the first list, there are C(n1,m)
possibilities for choosing m genes to be in common with
the second list. 4) In the second list, besides the m genes
that are in common with the first list, the remaining n2 −m
genes are chosen among the n− n1 “leftover” genes not in
the first list, thus C(n−n1, n2−m) possibilities. The P (m)
is simply (#2 × #3 × #4) / #1. Note that n1 and n2 can be
switched without changing the P (m) value.
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Fig. 1. First column: proportion of overlapping genes between two top
ranking gene lists for a pair of studies (m/n1) as a function of the gene list
length (n1(= n2)). Top is for gene ranking by t-test and bottom is for gene
ranking by logistic regression. The overlapping proportion for two randomly
shuffled lists is shown in crosses, and the line m/n1 = n1/n is marked.
Second column: observed number of overlapping genes (m) subtract the
expected number of overlapping genes (n2
1
/n).
It is usually more interesting to calculate the sum of P (m)
for m’s equal or larger than the observed value (i.e., the p-
value):
p-value =
min(n1,n2)∑
k=m
p(k) =
min(n1,n2)∑
k=0
p(k)−
m−1∑
k=0
p(k)
In statistical package R (http://www.r-project.org/), there are
at least two ways to calculate the overlapping p-value. The
first is to use the accumulative distribution of hypergeo-
metric distribution, phyper(m, n1, n − n1, n2): p-value =
phyper(min(n1, n2), n1, n−n1, n2)−phyper(m−1, n1, n−
n1, n2) if m > 0, and p-value=1 if m = 0. The second
method is to use the p-value from the Fisher’s exact test on
the following 2-by-2 table:
col1 col2 total
row1 m n1 −m n1
row2 n2 −m n− n1 − n2 +m n− n1
total n2 n− n2 n
The two approaches lead to the identical result.
III. PROPORTION OF OVERLAPPING GENES IN A
COLLECTION OF MICROARRAY DATASET
In hypergeometric distribution, the number of overlapping
elements m is an independent variable from the the list
lengths n1, n2. In order to get a rough idea on how m
changes with the list lengths, we use three real microarray
datasets. Theese studies concern three autoimmune diseases:
rheumatoid arthritis (RA), systemic lupus erythematosus
(SLE), and psoriatic arthritis (PsA), described in details
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Fig. 2. Overlapping significance as measured by − log
10
(p-value) where
p-value is obtained by the hypergeometric distribution, as a function of
n1(= n2), the number of genes in the top-ranking gene lists. The R
program reports p-value to be zero whenever it is lower than 2.2×10−16,
and we use a ceiling of 15.65758 = − log10(2.2×10−16) in the plot. Six
lines are shown for three study pairs (RA-SLE, SLE-PsA, RA-PsA) and two
tests/models (t-test and logistic regression). Similar overlapping significance
for two randomly shuffled lists is also shown (indicated by crosses).
in [11], [12], [13]. The number of controls (C) and pa-
tients (P) in these three datasets are (C=39, P=46), (C=41,
P=81), and (C=19, P=19), respectively. The total number
of genes/probe-sets is n =22283, and the expression levels
are log transformed. Genes are ranked for their degree of
differential expression which can be measured by various
tests or models, such as t-test and logistic regression.
For any pair of studies, with a fixed number of top-
ranking gene lists n1(= n2), one can count the number of
overlapping genes m and the proportion m/n1(= m/n2).
Fig.1 (left column) shows this proportion as a function of
n1(= n2) for three study-pairs (RA-SLE, SLE-PsA, RA-
PsA) as well as for two ranking methods (t-test and logistic
regression). Similar overlapping proportion of two random
shuffled lists is also indicated in Fig.1 as crosses.
When n1(= n2) is small, m is more likely to be zero, so
the proportion is also zero. When n1(= n2) approaches the
total number of genes, n, all genes are overlapping genes,
and the proportion is 1. Fig. 1 indeed shows these trends
at the two extreme points. In order to check behavior in-
between, we draw a reference line in Fig.1 (left column) that
assume a linear relationship between m/n1 and n1/n. Most
of the points on Fig.1 are above this line, and the overlapping
proportion of two random lists is exactly on this line.
To have an idea of the absolute number of common
genes more than expected by random chance, Fig.1 (right
column) plots the observed m subtract the expected mexp =
n21/n(= n
2
2/n) as a function of n1(= n2). The maximum
difference between the observed and expected is reached
between n1 = 5000 and n1 = 10000. The difference of
observed and expected m’s can be as much as 600–800.
IV. OVERLAPPING SIGNIFICANCE
The overlapping p-value corresponding to the m counts
plotted in Fig.1 was calculated by the hypergeometric distri-
bution, and is shown in Fig.2: y-axis is − log10(p-value), and
x-axis is n1(= n2). Six lines are shown for three compar-
isons (RA-SLE, SLE-PsA, RA-PsA) and two measurements
of the differential expression (t-test and logistic regression).
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Fig. 3. The test significance (− log
10
(p-value)) from t-test of n =22283
genes sorted by the averaged expression level (log-transformed) across all
245 samples in 3 studies (RA, SLE, PsA). The three t-tests are for RA vs.
control, SLE vs. control, and PsA vs. control.
Zero p-values are converted to 2.2 ×10−16 which is the
minimum value reported by R program. Fig.2 shows that
besides the two ends (m = n1 = n2 = 0 and m = n1 =
n2 = n) where the p-value is 1, the overlapping significance
quickly increases with the length of top-ranking gene list
n1(= n2), and can be extremely significant when a large
number of genes are kept in the two lists for comparison.
This result confirm our previous suspicion that overlapping
significance is a function of the gene list lengths. If the
selection of n1, n2 is arbitrary, the overlapping significance
thus calculated is also arbitrary. It is not surprising that
overlapping significance may keep increasing (or, p-value
decreasing) with the increase of n1(= n2), because p-value
in general depends on the sample size. When a signal is real
(true positive), p-value will monotonically decrease with the
sample size. On the contrast, if a true signal is absent, the
sample size does not affect the conclusion. As can be seen
in Fig.2, the overlapping significance for two random lists
does not really change with n1(= n2).
One may argue that it is unlikely to consider top 5000
genes as being differentially expressed, because by a typical
selection criterion (e.g. p-value of t-test smaller than 0.01,
with or without multiple testing correction), the number of
genes selected is less than a few hundreds. However, as can
be seen in Fig.2, even in the range of 10–500, the overlapping
p-value changes dramatically.
This pitfall of gene-list-length dependence of overlapping
p-values has not been noticed before perhaps because in other
application of hypergeometric distribution for calculating
overlapping probability, the length of the second list n2
is fixed, for example, in the study of overrepresentation
of genes in certain pathway. The number of overlapping
genes m is then constrained from above by min(n1, n2)
even though the length of the first list, n1, might increase by
relaxing the gene selection criterion.
V. THE EFFECTS OF UNEXPRESSED GENES
There are many genes/probe-sets on the microarray chip
that do not register much signal. Since these low-expressed
genes are lowly expressed in both control and patient sam-
ples, they usually do not appear in the top-ranking differen-
tially expressed gene list. Fig.3 shows − log10(p-value) of
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Fig. 4. Several measures of overlapping genes between a pair of studies as
a function of the number of genes included in the top-ranking list, for the
reduced dataset with 15283 genes. First column: proportion of overlapping
genes (m/n1); second column: number of observed overlapping genes sub-
tracting the number of expected (m−n2
1
/15283); third column: − log10(p-
value) by the hypergeometric distribution. First row is for lists ranked by
t-test result, and second row is for lists ranked by logistic regression.
each gene of 3 t-tests sorted by average expression (log-
transformed) across all 245 samples in 3 datasets (for both
cases and controls). Although we cannot use the average ex-
pression level to predict the degree of differential expression,
there is a general trend for low-expressed genes to rank lower
in the differentially expressed list as seen from Fig.3.
We removed 7000 genes with lower overall expression
across all samples, leaving n = 15283 genes. Figs.1 and
2 are reproduced in Fig.4 for the dataset with a reduced
gene pool. As in Figs.1 and 2, the observed number of
overlapping genes m is much larger than the expected,
though the difference peaks at 400–600, as versus 600-800 in
Fig.1. The overlapping significance as measured by − log(p-
value) again quickly moves up with n1(= n2) as shown in
the last column of Fig.4.
The qualitative similarity between Figs.1, 2 and Fig.4
indicates that the presence of low-expressed genes does not
affect our conclusion.
VI. CONCLUSIONS AND FUTURE WORKS
A. Conclusions
Using the hypergeometric distribution to calculate the
overlapping probability between two top-ranking differen-
tially expressed genes in two studies, we have shown that the
overlapping significance depends on the stringency of gene
selection criterion, or equivalently, the length of the gene
lists. This observation presents a problem when an overlap-
ping p-value is reported but the gene selection criterion is not
specified. On the other hand, the increase of the overlapping
significance with the gene list length can be an indication
that the significant overlapping of genes is a true signal.
B. Future Works
The overlapping probability calculated here assumes the
two top-ranking gene lists are selected from the same pool
of n genes. If the two studies are based on different chip
platforms, the two initial gene pools are not identical, though
there are perhaps certain common genes. We plan to derive
the overlapping distribution for this situation.
We also plan to study the probability for genes appearing
in three top-ranking gene lists. Although a permutation based
approach comparing multiple studies was proposed in [14],
there is no analytic formula available.
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